相关实验视频

Updated: Jul 1, 2025

Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring

Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring

Published on: August 17, 2022

自身免疫性疾病和不良妊娠结果:一个总体审查

Megha Singh¹, Steven Wambua¹, Siang Ing Lee¹

¹Institute of Applied Health Research, University of Birmingham, Birmingham, UK.

|March 4, 2024

概括

患有自身免疫性疾病的女性面临着更高的妊娠不良结果的风险,如流产,子宫前和早产. 这一总体综述强调了改善孕产妇护理的关键关联和研究缺口.

科学领域:

产科和妇科产科和妇科
类风湿病学类风湿病学
免疫学免疫学免疫学

背景情况:

自免疫性疾病在女性中普遍存在,特别是在生殖年龄.
自身免疫性疾病和不良妊娠结果之间的联系是一个重要的临床问题.
现有的研究往往侧重于特定的条件,需要一个整合的概述.

研究的目的:

巩固现有关于自身免疫性疾病和不良妊娠结果之间的关联的知识.
为了确定特定的自身免疫性疾病和妊娠并发症与最高的风险关联.
确定当前研究中的差距,以便在未来进行调查.

主要方法:

进行了对系统性审查和元分析的综合性审查.
在Medline,Embase和Cochrane数据库中进行了搜索,截至2023年12月.
数据合成涉及叙事和定量方法,报告相对风险 (RR) 和几率比率 (OR) 以95%的置信区间.

主要成果:

32项综述包括709项研究,检查了12种自身免疫性疾病和16种不良妊娠结果.
观察到流产 (Sjögren综合征,SLE),妊娠前 (T1DM,SLE) 和早产 (T1DM,SLE) 的风险增加.
发现子宫内生长受限 (全身性硬化症,腹腔疾病) 和死产 (T1DM,IBD,腹腔疾病) 的风险增加.

结论:

患有自身免疫性疾病的孕妇具有显著更高的妊娠不良结果风险.
进一步的研究至关重要,以告知增强的孕前,产前和产后护理策略.
针对这种高风险人群,需要有针对性的干预措施和改进的管理协议.

关键词:

自身免疫性疾病是一种自身免疫性疾病.怀孕怀孕怀孕怀孕怀孕并发症怀孕并发症

更多相关视频

Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface

Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface

Published on: May 21, 2015

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

相关概念视频

Autoimmune Disorders

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...

Development of Immunocompetence

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

Teratogenicity

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

Transcytosis of IgG

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...